Trademarkia Logo

Canada

C$
LACTOBACILLUS PLANTARUM DR7
REGISTERED

on 22 Mar 2023

Last Applicant/ Owned by

AB-BIOTICS S. A.

Av. de la Torre Blanca, 57 ESADE CreapolisE-08172 Sant Cugat del Vallès

ES

Serial Number

2002334 filed on 15th Nov 2019

Registration Number

TMA1171869 registered on 22nd Mar 2023

Registration expiry Date

15th Nov 2029

Correspondent Address

KIRSTEN SEVERSON

(KLS TRADEMARK SERVICES)PO BOX 191264TH AVENUE POSTAL OUTLETVANCOUVER

BRITISH COLUMBIA

CA

V6K4R8

LACTOBACILLUS PLANTARUM DR7

Trademark usage description

pharmaceutical products namely pharmaceutical preparations for the treatment of upper respiratory tract infections, common colds, flu and fever; pharm Read More

Classification Information


Class [005]
Pharmaceutical products namely pharmaceutical preparations for the treatment of upper respiratory tract infections, common colds, flu and fever; pharmaceutical products for boosting immune response; pharmaceutical products for the treatment of stress, anxiety and cognitive functions; intestinal disorder medicine for the treatment of intestinal bacteria and parasites; pharmaceutical and natural remedies namely homeopathic remedies for the treatment of inflammatory diseases, namely, upper respiratory track infections, colds, flu, fever; homeopathic remedies for treatment of stress, anxiety and cognitive functions; natural dietary supplements for treating intestinal bacteria; veterinary preparations namely veterinary preparations for treatment of upper respiratory tract infections; veterinary preparations for treatment of intestinal bacteria; pharmaceutical preparations namely anti-inflammatory preparations; pharmaceutical preparations for regulating intestinal microbiota; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of upper respiratory tract infections, common colds, flu and fever; pharmaceutical preparations for boosting immune response; pharmaceutical preparations for the treatment of stress, anxiety and cognitive functions; intestinal disorder medicine for the treatment of intestinal bacteria and parasites; food for babies; dietetic preparations and supplements namely dietetic substances consisting of probiotics dietetic supplements for animals namely dietary supplements consisting of probiotics for animals; dietetic animal feed supplements; materials for dental fillings; dental impression materials; herbicides; fungicides; food additives for medical use namely probiotics for use as an additive to foods for medical purposes; nutritional supplements namely nutritional supplements consisting of probiotics; nutritional supplements for general health and well-being; dietary supplements namely dietary supplements consisting of probiotics; dietary supplement drink mixes for general health and wellbeing; dietary supplements for humans, not for medical purposes namely dietary supplements for general health and wellbeing; dietary supplements with cosmetic effect namely dietary supplements for anti-aging; dietetic supplements for humans namely probiotics for use as dietary supplements; dietary supplements for medical use namely probiotic dietary supplements for medical use; dietetic beverages for babies adapted for medical purposes; nutritional supplements for animal foodstuffs, for medical purposes; probiotic bacterial formulations for medical use namely probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system; probiotic preparations for medical use to help maintain the natural balance of the digestive flora; bacterial preparations for medical or veterinary use namely veterinary pharmaceutical preparations for the treatment of bacterial and viral infections in dogs; bacteriological preparations for medical or veterinary use namely animal feed supplements for veterinary purposes; bacteriological preparations for pharmaceutical use namely bacteriological culture mediums.


Classification kind code

11

Mark Details


Serial Number

2002334

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 26th Oct 2021
Agent Changed
Submitted for opposition 22
on 14th Apr 2021
Search Recorded
Submitted for opposition 20
on 14th Apr 2021
Examiner's First Report
Submitted for opposition 223
on 14th Apr 2021
Total Provisional Refusal
Submitted for opposition 256
on 19th Oct 2020
Notification of Possible Opposition Sent
Submitted for opposition 257
on 19th Dec 2019
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Dec 2019
Created
Submitted for opposition 31
on 19th Dec 2019
Formalized
Submitted for opposition 30
on 15th Nov 2019
Filed
Submitted for opposition 228
on 15th Nov 2019
International Registration